Articles
Trials in autoimmune disease
Giving children their own cord blood to prevent them getting type 1 diabetes and development of a new immunotherapy are part of a more tailored approach to treating autoimmune diseases. [ + ]
Prime Minister announces Medical Technologies Innovation Partnership
Prime Minister Kevin Rudd last week announced the Medical Technologies Innovation Partnership - the first of the Australian Innovation Partnership program. The program is intended to create partnerships between government, business and the research community that will create new high-skill jobs for the future. [ + ]
Genes, male beauty and attractiveness to the other gender
It’s a simple fact: some individuals are more attractive to the opposite sex than others. But what makes them more desirable? [ + ]
Consultation on cost recovery for gene technology regulator
The Department of Health and Ageing (DoHA) is undertaking an assessment and development of a cost recovery model for services provided by the Office of the Gene Technology Regulator (OGTR). DoHA has engaged PricewaterhouseCoopers (PwC) to undertake an economic analysis of the gene technology sector, and PwC is seeking input from sector stakeholders through the stakeholder survey. [ + ]
So you’re thinking of buying a LIMS
A good laboratory information management system (LIMS) can make a huge improvement to a laboratory’s productivity. [ + ]
Following the herd: the influence of online ratings
The comments section of online news sites is intended to be a place where everyone can express their own opinion. But according to a study published in the journal Science, many people are heavily influenced by the positive opinions of others in such outlets, while less swayed by the negative ones. [ + ]
Mimicking a cure
A collaboration of Melbourne scientists who describe themselves as a “happy confluence” is shedding much-needed light on how the body controls nervous system myelination, and how their tiny peptide ‘mimic’ could help patients with neurodegenerative disease. [ + ]
CSL boosts FY13 profit by 19%
CSL (ASX:CSL) recorded 19% higher profit for FY13 as well as 7% higher revenue, and has announced the appointment of a new director. [ + ]
One chemical - two crystal colours
A surprise for chemists studying agostic bonds was the development of crystals of two different colours from one chemical in one flask. [ + ]
AmpliPhi presents CF lung data at phage summit
AmpliPhi BioSciences has used the Evergreen International Phage Meeting to present data supporting the effectiveness of bacteriophage treatments in P. aeruginosa infections. [ + ]
Six tips for selecting a laboratory workstation
Buying technician workstations for your laboratory is a major capital expense, deserving of careful consideration to avoid making a costly mistake. Follow these six tips for selecting a laboratory workstation that meets all your current needs, while positioning you to adapt to whatever comes down the parkway. [ + ]
Patrys myeloma trial to move to final group
Patrys (ASX:PAB) has received safety board approval to move to the final group in its multidose escalation study of PAT-SM6 in multiple myeloma. [ + ]
DNA - a silent witness
Forensic science is about to be transformed with the use of new technology to predict a person’s physical appearance - a molecular photofit derived from DNA found at a crime scene. [ + ]
Cost-effectively convert a conventional microscope into a billion-pixel imaging system
Usually microscopists have to decide between high resolution and a small field of view or low resolution and a large field of view. But that need no longer be the case. [ + ]
Engaging the unengaged in science? Try a little harder
The strange but true fact is: not everybody is absolutely fascinated by science, nor thinks it is vital. [ + ]